Diagnostics

Driven by nanotechnology using our patented fluorescent 'nano diamond particle' system, our team of medical researchers have created a platform that is a replacement for PCR testing, which can detect any infectious disease, from covid-19 to Ebola or even the common flu, the cure for which is here. With results in under 10 seconds, which are relayed directly onto the cloud, we have the most advanced 'point of entry' testing system anywhere in the world.

Unlike other tests which require a swab to be inserted into the nose and throat, our test is non-invasive, meaning it only requires a small sample of saliva onto our device making it a lot more comfortable. Once the sample has been taken, it is inserted into our portable reader which gives results in approximately 10 seconds. The same results are also relayed onto a cloud system online to enable detection of any viral surges.

Our platform can potentially detect any infectious disease, from the common flu, to covid-19 and other more dangerous diseases such as Ebola. What makes out platform unique is the ability to detect multiple infections simultaneously. For instance, the ability to test for covid-19 and the common flu at the the same time, additionally uniquely able to detect yet 'undiscovered' variants of a disease helping to alert authorities of a new potential biohazard.

Our platform is portable, and also runs on solar power, meaning it can be used everywhere from airports, to offices, restaurants, stadiums, government buildings such as hospitals, or even in areas where there is no access to electricity. The ability for rapid results makes it possible to now prevent lock-down scenarios ever happening again. It's non-invasive nature means even young children at school can rapidly be tested.